Strategic Financial Concepts LLC Purchases New Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Strategic Financial Concepts LLC purchased a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 27,168 shares of the exchange traded fund’s stock, valued at approximately $2,447,000.

Other institutional investors have also recently made changes to their positions in the company. Golden State Wealth Management LLC bought a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter valued at about $29,000. Avior Wealth Management LLC raised its stake in SPDR S&P Biotech ETF by 393.6% in the fourth quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after buying an additional 307 shares during the period. Tidemark LLC lifted its position in shares of SPDR S&P Biotech ETF by 101.5% in the third quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock valued at $39,000 after buying an additional 199 shares during the last quarter. Quintet Private Bank Europe S.A. bought a new position in shares of SPDR S&P Biotech ETF during the 3rd quarter worth approximately $40,000. Finally, Howe & Rusling Inc. acquired a new position in shares of SPDR S&P Biotech ETF during the 3rd quarter worth approximately $49,000.

SPDR S&P Biotech ETF Price Performance

Shares of SPDR S&P Biotech ETF stock opened at $91.41 on Tuesday. The business has a fifty day simple moving average of $91.63 and a two-hundred day simple moving average of $96.06. SPDR S&P Biotech ETF has a 1 year low of $81.14 and a 1 year high of $105.47. The company has a market capitalization of $6.97 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.